Artwork

İçerik Kim Carlos tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Kim Carlos veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

Ozempic 101: Addressing Side Effects, Myths, and FAQs for Weight Loss with Dr. Kumar Part 2

59:30
 
Paylaş
 

Manage episode 471904614 series 3465852
İçerik Kim Carlos tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Kim Carlos veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Resources for the Community:

___________________________________________________________________

Ro - Telehealth for GLP1 weight management

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

______________________________________________________________________

Part 2

This discussion delves into GLP-1 therapies for weight loss, offering expert insights from Dr. Rekha Kumar, Chief Medical Officer at Found, a leading telehealth service for GLP-1 prescriptions. Dr. Kumar, a PCP specializing in obesity and endocrinology, shares key advice on managing common concerns, including myths about GLP-1s, side effect management, and optimizing diet, hydration, and fitness for GLP-1 users.

We explore the science behind weight loss plateaus, the body’s resistance to weight loss, and strategies to overcome stalls. The conversation highlights Found’s unique, individualized approach to weight loss, focusing on root causes and long-term management with GLP-1 therapies. We also discuss how Found addresses FDA drug shortages, manages compounded prescriptions, and ensures patient compliance. This overview provides valuable insights for patients and healthcare professionals seeking sustainable solutions for obesity management.

______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF

______________________________________________________________________

Join this channel to get access to perks:

/ @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy

Support the show

Kim Carlos, Executive Producer

TikTok

https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr

Kat Carter, Associate Producer

TikTok

https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

  continue reading

152 bölüm

Artwork
iconPaylaş
 
Manage episode 471904614 series 3465852
İçerik Kim Carlos tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Kim Carlos veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Resources for the Community:

___________________________________________________________________

Ro - Telehealth for GLP1 weight management

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

______________________________________________________________________

Part 2

This discussion delves into GLP-1 therapies for weight loss, offering expert insights from Dr. Rekha Kumar, Chief Medical Officer at Found, a leading telehealth service for GLP-1 prescriptions. Dr. Kumar, a PCP specializing in obesity and endocrinology, shares key advice on managing common concerns, including myths about GLP-1s, side effect management, and optimizing diet, hydration, and fitness for GLP-1 users.

We explore the science behind weight loss plateaus, the body’s resistance to weight loss, and strategies to overcome stalls. The conversation highlights Found’s unique, individualized approach to weight loss, focusing on root causes and long-term management with GLP-1 therapies. We also discuss how Found addresses FDA drug shortages, manages compounded prescriptions, and ensures patient compliance. This overview provides valuable insights for patients and healthcare professionals seeking sustainable solutions for obesity management.

______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF

______________________________________________________________________

Join this channel to get access to perks:

/ @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy

Support the show

Kim Carlos, Executive Producer

TikTok

https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr

Kat Carter, Associate Producer

TikTok

https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

  continue reading

152 bölüm

Alle afleveringen

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi

Keşfederken bu şovu dinleyin
Çal